Shares of Unichem Laboratories jumped over 7 per cent on the Bombay stock Exchange after the drug maker said that its formulations manufacturing facility at Ghaziabad has received an Establishment Inspection Report (EIR) from the USFDA.
Boosted by the development, shares of the company gained as much as 6.98 per cent to hit intra-day high of Rs 264.10 apiece on the Bombay Stock Exchange. The scrip was currently trading at Rs 249.50 against previous close price of Rs 246.85.
In a similar fashion, stocks of company were trading 1.24 per cent higher at Rs 249.00 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 31,322.09, up 131.52 points or 0.42 per cent, at 10:45 hours.